<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02546596</url>
  </required_header>
  <id_info>
    <org_study_id>YURO-H1</org_study_id>
    <nct_id>NCT02546596</nct_id>
  </id_info>
  <brief_title>The Effect of Electro-Hyperthermia in Preoperative Radiotherapy for Locally Advanced Rectal Cancer</brief_title>
  <official_title>The Effect of Electro-hyperthermia in Preoperative Radiotherapy Followed by Delayed Operation for Locally Advanced Rectal Cancer: Phase II Single Institutional Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yonsei Hyperthermia Study Group</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Yonsei Hyperthermia Study Group</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Preoperative radiotherapy in locally advanced rectal cancer increases the possibility of&#xD;
      complete resection and anal sphincter preservation. However, a treatment period of from 5 to&#xD;
      6 weeks is an obstacle of proper surgical intervention. Also, radiotherapy itself is&#xD;
      confronting challenges for maximizing the therapeutic effect and minimizing the side effects.&#xD;
      Electro-hyperthermia is appropriate treatment method to solve these kinds of problems. In&#xD;
      this clinical trial, therapeutic effect of the high-frequency electro-hyperthermia is to be&#xD;
      verified during preoperative radiotherapy for locally advanced rectal cancer. The ultimate&#xD;
      goal is to establish a safe and effective treatment protocol.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Preoperative radiotherapy in locally advanced rectal cancer increases the possibility of&#xD;
      complete resection and anal sphincter preservation. However, a treatment period of from 5 to&#xD;
      6 weeks is an obstacle of proper surgical intervention. Also, radiotherapy itself is&#xD;
      confronting challenges for maximizing the therapeutic effect and minimizing the side effects.&#xD;
      Electro-hyperthermia is appropriate treatment method to solve these kinds of problems. In&#xD;
      this clinical trial, therapeutic effect of the high-frequency electro-hyperthermia is to be&#xD;
      verified during preoperative radiotherapy for locally advanced rectal cancer. The endpoint of&#xD;
      the trial is treatment safety and non-inferiority of tumor regression to conventional&#xD;
      schedule of preoperative radiotherapy.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">March 25, 2014</start_date>
  <completion_date type="Anticipated">February 28, 2022</completion_date>
  <primary_completion_date type="Actual">December 15, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>T stage (0 - 4), N (0 - 3) stage, tumor regression grade (0 - 4)</measure>
    <time_frame>3 months after curative surgery by surgical pathology report</time_frame>
    <description>surgical pathology report</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Treatment toxicity (grade 0 - 5)</measure>
    <time_frame>5 years after curative surgery by clinical assessments</time_frame>
    <description>clinical assessments</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">76</enrollment>
  <condition>Rectal Cancer</condition>
  <condition>Hyperthermia</condition>
  <arm_group>
    <arm_group_label>Electro-hyperthermia plus radiation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>External beam radiation 40 Gy with 20 fractions (4 weeks) Electro-hyperthermia twice a week, one hour for each session</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Electro-hyperthermia</intervention_name>
    <description>Addition of electro-hyperthermia to radiation</description>
    <arm_group_label>Electro-hyperthermia plus radiation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Pathologically-proven rectal adenocarcinoma within 15 cm from anal verge&#xD;
&#xD;
          -  Clinically T3-4 stage or positive lymph nodes&#xD;
&#xD;
          -  Performance status 0-2&#xD;
&#xD;
          -  Proper function of bone marrow, kidney, and liver&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Past disease history of rectum&#xD;
&#xD;
          -  Hereditary colorectal cancer&#xD;
&#xD;
          -  Chronic inflammatory bowel disease&#xD;
&#xD;
          -  Bower stenosis&#xD;
&#xD;
          -  Active infection&#xD;
&#xD;
          -  Myocardial infarction, uncontrolled arrhythmia, angina pectoris, or cardiac&#xD;
             insufficiency within 6 months&#xD;
&#xD;
          -  Pregnancy, nursing&#xD;
&#xD;
          -  Unresected contemporary colon cancer&#xD;
&#xD;
          -  Thermal hypersensitivity&#xD;
&#xD;
          -  Too much subcutaneous fat in the abdominal and pelvic area&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sei Hwan You, MD</last_name>
    <role>Study Director</role>
    <affiliation>Yonsei Hyperthermia Study Group</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Wonju Severance Christian Hospital</name>
      <address>
        <city>Wonju</city>
        <state>Gangwon</state>
        <zip>220-701</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>September 6, 2015</study_first_submitted>
  <study_first_submitted_qc>September 8, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 11, 2015</study_first_posted>
  <last_update_submitted>July 12, 2021</last_update_submitted>
  <last_update_submitted_qc>July 12, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 13, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rectal Neoplasms</mesh_term>
    <mesh_term>Hyperthermia</mesh_term>
    <mesh_term>Fever</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

